Testosterone isovalerate

Testosterone isovalerate
Clinical data
Other namesTestosterone isopentanoate; Testosterone 17β-isovalerate; Androst-4-en-17β-ol-3-one 17β-isovalerate
Routes of
administration		Intramuscular injection
Identifiers
IUPAC name
  • (1S,2R,10R,11S,14S,15S)-2,15-Dimethyl-5-oxotetracyclo[8.7.0.02,7.011,15]heptadec-6-en-14-yl 3-methylbutanoate
ChemSpider
Chemical and physical data
FormulaC24H36O3
Molar mass372.549 g·mol−1
3D model (JSmol)
SMILES
  • CC(C)CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChI
  • InChI=1S/C24H36O3/c1-15(2)13-22(26)27-21-8-7-19-18-6-5-16-14-17(25)9-11-23(16,3)20(18)10-12-24(19,21)4/h14-15,18-21H,5-13H2,1-4H3/t18-,19-,20-,21-,23?,24?/m0/s1
  • Key:MTDSXXUEXHCLTL-PKLKGOOFSA-N

Testosterone isovalerate, also known as testosterone isopentanoate, testosterone 17β-isovalerate, and androst-4-en-17β-ol-3-one 17β-isovalerate, is a synthetic, injected anabolic-androgenic steroid (AAS) and an androgen ester – specifically, the C17β isovalerate (isopentanoate) ester of testosterone – which was never marketed.[1][2] It is a prodrug of testosterone and, when administered via intramuscular injection, is associated with a long-lasting depot effect and extended duration of action.[1]

See also

References

  1. 1 2 Vitamins and Hormones. Academic Press. 1 January 1944. pp. 382–. ISBN 978-0-08-086599-7.
  2. ↑ Josephy E, Radt F (1 December 2013). Elsevier's Encyclopaedia of Organic Chemistry: Series III: Carboisocyclic Condensed Compounds. Springer. pp. 3031–. ISBN 978-3-662-25863-7.


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.